Lippoldt Darin
Neurocrine Biosciences Inc · Chief Legal Officer
Lippoldt Darin is listed in public filings as officer: Chief Legal Officer. This Lippoldt Darin insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Neurocrine Biosciences Inc (NBIX). Investors use Lippoldt Darin's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $4.3M34.9k shares | Grant / ExerciseFeb 13, 2026 | $4.3M34.9k shares | $124.12 | -- | |
| $6.8M55.1k shares | Grant / ExerciseFeb 13, 2026 | $667.5K5.4k shares | $124.12 | -- | |
| --2.1k shares | Grant / ExerciseFeb 13, 2026 | Disclosure amount unavailable2.1k shares | -- | -- | |
| --4k shares | Grant / ExerciseFeb 13, 2026 | Disclosure amount unavailable2k shares | -- | -- | |
| --6.1k shares | Grant / ExerciseFeb 13, 2026 | Disclosure amount unavailable6.1k shares | -- | -- | |
| --54.7k shares | Grant / ExerciseFeb 13, 2026 | Disclosure amount unavailable365 shares | -- | -- | |
| --60.5k shares | Grant / ExerciseFeb 13, 2026 | Disclosure amount unavailable10k shares | -- | -- | |
| $6.3M50.5k shares | Grant / ExerciseFeb 13, 2026 | $139.5K1.1k shares | $124.12 | -- | |
| $6.1M49.5k shares | Grant / ExerciseFeb 13, 2026 | $135.2K1.1k shares | $124.12 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --5.4k shares | Grant / ExerciseFeb 12, 2026 | Disclosure amount unavailable1.8k shares | -- | -- | |
| $6.0M48.6k shares | Grant / ExerciseFeb 12, 2026 | $119.0K967 shares | $123.10 | -- | |
| --2.4k shares | Grant / ExerciseJan 31, 2026 | Disclosure amount unavailable2.4k shares | -- | -- | |
| $6.5M47.8k shares | Grant / ExerciseJan 31, 2026 | $181.6K1.3k shares | $136.06 | -- | |
| $03.3k shares | Grant / ExerciseJan 8, 2026 | $120.5K3.3k shares | $35.99 | -- | |
| $6.9M43.4k shares | SellDec 8, 2025 | $698.6K4.4k shares | $159.65 | -- | |
| $04.4k shares | Grant / ExerciseDec 8, 2025 | $189.2K4.4k shares | $43.24 | -- |